"Who cares if it wasn't?" That's hilarious.
Shall we go to FDA on the strength of the in-house?
A DB-RCT is the gold standard mate. It failed to validate your in-house study. Thus your sp is pus.
The market cares.
Any reputable scientific journal cares.
Heck, the whole medical community cares.
The only one who doesn't is you.
Conference Call Summary, page-459
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?